This Web site may contain forward-looking statements, which express the current beliefs and expectations of the management of Agennix AG, including statements about our cash position and net cash burn, the likelihood of Agennix AG entering into a partnering agreement or similar collaboration, the future development of our drug candidates, and the potential efficacy and safety profile of our drug candidates.

Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future outcomes to differ significantly from the outcomes expressed or implied by such forward-looking statements.

Actual outcomes could differ materially depending on a number of factors, and we caution investors not to place undue reliance on the forward-looking statements contained in this Web site. Forward-looking statements speak only as of the date on which they are made, and Agennix undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future.